Erythrovirus B19 infection in humans

Indian Journal of Medical Research

Volumn 112, Issue NOV., 2000, Pages 149-164

  Kishore, J ^a   Kapoor, A ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Erythrovirus B19; Parvovirus B19; Viral infections

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN M ANTIBODY; VIRUS CAPSID ANTIGEN; VIRUS DNA; IMMUNOGLOBULIN M;

ARTHRALGIA; CELL CYCLE S PHASE; CHILDHOOD DISEASE; DISEASE TRANSMISSION; ENDOTHELIUM CELL; ERYTHEMA INFECTIOSUM; ERYTHROCYTE DISORDER; ERYTHROID PRECURSOR CELL; FETUS HYDROPS; HEART; HEMATOLOGIC DISEASE; HEPATITIS; HUMAN; IMMUNOPATHOLOGY; INDIA; KIDNEY; MEGAKARYOBLAST; NONHUMAN; PARVOVIRUS; REVIEW; RHEUMATOID ARTHRITIS; UPPER RESPIRATORY TRACT; VIRUS CELL INTERACTION; GENETICS; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS INFECTION; VIRUS REPLICATION;

DNA, VIRAL; HUMAN; IMMUNOGLOBULIN M; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; VIRUS REPLICATION;

EID: 0034527632     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. Parvovirus-like particles in human sera
2. The transfusion-associated transmission of parvovirus B19
3. The prevalence of antibody to human parvovirus B19 in England and Wales
4. Human parvovirus, the cause of erythema infectiosum (fifth disease)?
5. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia
6. Human parvovirus-associated arthritis: A clinical and laboratory description
7. Human parvovirus arthropathy
8. Human parvovirus infection in pregnancy and hydrops foetalis
9. Chronic bone marrow failure due to persistant B19 parvovirus infection
10. Parvovirus B19 infection
11. Rheumatologic manifestations of human parvovirus B19 infection in adults
12. Detection of parvovirus in a patient with 'reactive arthritis' by in situ hybridization
13. Raised IgM antibodies to parvovirus B19 in juvenile rheumatoid arthritis
14. Human parvovirus B19-associated arthritis in children
15. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy
16. Virus taxonomy-Classification and nomenclature of viruses
17. Identification of a novel simian parvovirus in cynomolgus monkeys with severe anaemia. A paradigm of human B19 parvovirus infection
18. Novel human erythrovirus associated with transient aplastic anaemia
19. Architecture with a difference
20. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini
21. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis
22. Parvovirus genome: Nucleotide sequence of H-land mapping of its genes by hybrid-arrested translation
23. Genomic clones of bovine parvovirus: Construction and effect of deletions and terminal sequence inversions on infectivity
24. Replication of parvoviral DNA. I. Characterization of a nuclear lysate system
25. Terminal hairpins of parvovirus genomes and their role in DNA replication
26. Replication of the B19 parvovirus in human bone marrow cell cultures
27. Palindromic base sequences and replication of eukaryote chromosome ends
28. A small virus in human faeces
29. Association of parvoviruses with rheumatoid arthritis of humans
30. Erythrocyte P antigen: Cellular receptor for B19 parvovirus
31. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen)
32. Tissue distribution of H, Lewis and P antigens as shown by a panel of 18 monoclonal antibodies
33. Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent?
34. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro
35. Successful replication of parvovirus B19 in the human megakaryocytic leukaemia cell line MB-02
36. Infection of aphresis cells by parvovirus B19
37. Experimental parvoviral infection in humans
38. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19)
39. B19 parvovirus replicates in circulating cells of acutely infected patients
40. Intrauterine infection with human pravovirus B19: A light and electron microscopy study
41. Ultrastructural features of foetal erythroid precursors infected with parvovirus B19 in vitro: Evidence of cell death by apoptosis
42. Human parvovirus B19 nonstructual (NSI) protein induces apoptosis in erythroid lineage cells
43. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anaemia
44. Human parvoviruses
45. Human parvovirus B19 specific IgG, IgA and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum
46. Characterisation of a virus that causes transient aplastic crisis
47. Immune response to B19 parvovirus and an antibody defect in persistent viral infection
48. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity
49. Prevalence of human parvovirus B19 and rubellavirus infections in urban and remote rural areas of northern Brazil
50. Human parvoviruses
51. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum
52. Human parvovirus aplasia: Case due to cross infection in a ward
53. Risk associated with human parvovirus B19 infection
54. Laboratory infection with parvovirus B19
55. Seroprevalence of anti-human parvovirus B19 antibodies in patients attending a centre for sexually transmitted diseases
56. Structure and mapping of the DNA of human parvovirus B19
57. Genetic diversity in the non-structural gene of parvovirus B19 detected by single-stranded conformational polymorphism assay (SSCP) and partial nucleotide sequencing
58. Analysis of genetic diversity in the VP1 unique region gene of human parvovirus B19 using the mismatch detection method and direct nucleotide sequencing
59. Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink
60. Clinical manifestations of human parvovirus B19 in adults
61. Occupational risk factors for infection with parvovirus B19 among pregnant women
62. Encephalitis associated with erythema infectiosum
63. Brachial plexus neuropathy associated with human parvovirus infection
64. Tonic pupils and human parvovirus (B19) infection
65. Chronic parvovirus infection in a presumably immunologically healthy woman
66. Epidemic erythema infectiosum
67. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
68. Persistance of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis
69. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: Evidence for B19 virus persistence
70. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis
71. Human parvovirus B19 infection among hospital staff members after contact with infected patients
72. Human serum 'parvovirus': A specific cause of aplastic crisis in children with hereditary spherocytosis
73. Case report: Aplastic crisis in sickle cell disorders: Bone marrow necroids and human parvovirus infection
74. B19 virus infection and aplastic crisis
75. The human parvovirus: Brief review
76. Prospective study of human parvovirus (B19) infection in pregnancy
77. Immunology and resistance to infection
78. Detection of parvovirus B19 DNA, antigen and particles in the human foetus
79. Parvovirus B19 infection of the foetus. Histology and in situ hybridisation
80. Antenatal diagnosis and palliative treatment of non-immune hydrops foetalis secondary to foetal parvovirus B19 infection
81. Clinical and histopathological features of parvovirus B19 infection in the human foetus
82. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: A prospective study
83. Risk factors for parvovirus B-19 infection in pregnancy
84. Parvovirus B19 associated with foetal abnormality
85. A foetus with a parvovirus B19 infection and congenital anomalies
86. Severe nonimmune hydrops foetalis and congenital corneal opacification secondary to human parvovirus B19 infection. A cases report
87. Erythropoiesis, hypoplastic anaemias, and disorders of haem synthesis
88. Persistent parvovirus B19 infections in humans
89. Parvovirus infection, leukaemia and immunodeficiency
90. Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia
91. Pure red-cell aplasia of 10 years duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy
92. Red cell aplasia caused by parvovirus B19 in AIDS: Use of i.v. immunoglobulin
93. Human parvovirus B19 is not a rare cause of anaemia in HIV seropositive individuals
94. Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to Zidovudine therapy
95. Parvovirus B19 infection-related complications in renal transplant recipients: Treatment with intravenous immunoglobulin
96. Aplastic anaemia due to B19 parvovirus infection in cadaveric renal transplant recipients: An underestimated infectious disease in the immunocompromised host
97. Human parvovirus B19-associated disease in bone marrow transplantation
98. Parvovirus B19 infection associated with myocarditis following adult cardiac transplantation
99. Parvovirus B19 infection in thoracic organ transplant recipients
100. Molecular, cellular and clinical aspects of parvovirus B19 infection
101. Parvovirus B19 infection, myocarditis and death in a three years old boy
102. Parvovirus B19-associated haemophagocytic syndrome with prominent neutrophilia
103. Encephalopathy with erythema infectiosum
104. Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient
105. Aseptic meningitis caused by human parvovirus B19
106. Human parvovirus and purpura
107. Parvovirus B19 and necrotising vasculitis
108. Active or recent parvovirus B19 infection in children with Kawasaki disease
109. Human parvovirus B19 infection in Kawasaki disease
110. Human parvovirus B19 infection in Kawasaki disease
111. Human parvovirus B19 infection in multiple sclerosis
112. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population
113. Human parvovirus B19 infection: Its relationship with sytemic lupus erythematosus
114. Acute cerebellar ataxia with human parvovirus B19 infection
115. Henoch-Schonlein syndrome associated with human parvovirus B19 primary infection
116. Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children
117. Conjunctivitis caused by human parvovirus B19 infection
118. Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro
119. Rapid and sensitive method for the detection of B19 virus DNA using the polymerase chain reaction with nested primers
120. Detection of B19 parvovirus infections by a dot-blot hybridization assay using a digoxigenin-labelled probe
121. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV)
122. Dot immunoperoxidase assay for detection of parvovirus B19 antigen in serum samples
123. Chemiluminescence Western blot assay for the detection of immunity against parvovirus B19 VP1 and VP2 linear epitopes using a videocamera based luminograph
124. Human parvovirus B19 infections; Routine diagnosis by a new nested polymerase chain reaction assay
125. Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA
126. Detection of human parvovirus B19 DNA by using the polymerase chain reaction
127. Rapid detection of human parvovirus B19 DNA by dot-hybridization and the polymerase chain reaction
128. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens
129. A rapid method of sample preparation for detection of DNA virus in human serum by polymerase chain reaction
130. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates
131. Transmission of human parvovirus B19 by coagulation factor concentratres
132. Detection of parvovirus B19 in donated blood: A model system for screening by polymerase chain reaction
133. Erythema infectiosum (fifth disease): Clinical review and description of 9 cases seen in an epidemic
134. Candidate recombinant vaccine for human B19 parvovirus
135. A new parvovirus: Similarities between monkeys and humans
136. Severe anaemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy